Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord

Developmental Brain Research

Volumn 108, Issue 1-2, 1998, Pages 147-160

  Hellström Lindahl, Ewa ^a   Gorbounova, Olga ^a   Seiger, Åke ^a   Mousavi, Malahat ^a   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytisine; Development; Epibatidine; Human brain; mRNA; Nicotinic receptor

Indexed keywords

NICOTINIC RECEPTOR;

ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; HUMAN; HUMAN TISSUE; NERVE FIBER GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SYNAPTOGENESIS; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ALKALOIDS; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; BRAIN CHEMISTRY; CEREBELLUM; CEREBRAL CORTEX; DNA PROBES; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MEDULLA OBLONGATA; MESENCEPHALON; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PEPTIDYLPROLYL ISOMERASE; POLYMERASE CHAIN REACTION; PONS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTEIN BINDING; PYRIDINES; QUINOLIZINES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; SPINAL CORD; TRITIUM;

EID: 0344588832     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00046-7     Document Type: Article

References (59)

1. 3H] nicotine binding sites in human brain J. Neurochem. 50:1988;1242-1247.
2. 3H] nicotine binding in human postmortem brain J. Pharmacol. Exp. Ther. 282:1997;7-13.
3. Brioni J., Decker M., Sullivan J., Arneric A. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv. Pharmacol. 37:1997;153-214.
4. 3H](-)nicotine binding sites in fetal human brain Brain Res. 475:1988;1-7.
5. Candy J.M., Perry E.K., Perry R.H., Bloxham C.A., Thompson J., Johnson M., Oakley A.E., Edwardson J.A. Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neurosci. Lett. 61:1985;91-95.
6. Chromczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
7. Cimino M., Martini P., Colombo S., Andena M., Cattabeni F., Fornasari D., Clementi F. Expression of neuronal acetylcholine nicotinic receptor α4 and β2 subunits during postnatal development of the rat brain. J. Neural. Transm. 100:1995;77-92.
8. Court J.A., Piggott M.A., Perry E.K., Barlow R.B., Perry R.H. Age associated decline in high affinity nicotinic binding in human brain frontal cortex does not correlate with changes in choline acetyltransferase activity. Neurosci. Res. Commun. 10:1992;125-133.
9. Court J.A., Perry E., Johnson M., Piggott M.A., Kerwin J.A., Perry R.H., Ince P.G. Regional pattern of cholinergic and glutamate activity in the developing and aging human brain. Dev. Brain Res. 74:1993;73-82.
10. Court J.A., Perry E.K., Spurden D., Griffiths M., Kerwin J.M., Morris C.M., Johnson M., Oakley A.E., Birdsall N.J.M., Clementi F., Perry R.H. The role of the cholinergic system in the development of the human cerebellum. Dev. Brain. Res. 90:1995;159-167.
11. Court J., Clementi F. Distribution of nicotinic subtypes in human brain. Alzheimer Dis. Assoc. Disorders. 9:1995;6-14. Suppl. 2.
12. Court J.A., Lloyd S., Johnson M., Griffiths M., Birdsall N.J.M., Piggott M.A., Oakley A.E., Ince P.G., Perry E.K., Perry R.H. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Dev. Brain Res. 101:1997;93-105.
13. Dominguez del Toro E., Juiz J.M., Smillie F.I., Lindstrom J., Criado M. Expression of α7 neuronal nicotinic receptors during postnatal development of the rat cerebellum. Dev. Brain Res. 98:1997;125-133.
14. Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A., Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M. Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2 and β4 subunits. J. Mol. Neurosci. 7:1996;217-228.
15. M.A. England, A colour atlas of life before birth, 2nd edn., Hazell books, Aylesbury, Bucks, England, 1990.
16. Falkeborn Y., Larsson C., Nordberg A., Slanina A. A comparison of the regional ontogenesis of nicotine- and muscarine-like binding sites in mouse brain. Int. J. Neurosci. 1:1983;286-289.
17. Flores C.M., Davila-Garcia M.I., Ulrich Y.M., Kellar K. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J. Neurochem. 69:1997;2216-2219.
18. Fried P.A., O'Conell C.A., Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J. Dev. Behav. Pediatr. 13:1992;383-391.
19. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
20. Gopalakrishnan M., Buisson B., Touma E., Giordano T., Campell J.E., Hu I.C., Donelly-Roberts D., Arneric S.P., Bertrand D., Sullivan J.P. Stable expression and pharmacological properties of the human α7 nicotinic receptor. Eur. J. Pharmacol. 290:1995;237-246.
21. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Progr. Neurobiol. 53:1997;199-237.
22. 3H] nicotine binding in the fetal brain Int. J. Dev. Neurosci. 3:1985;567-571.
23. Haglund B., Cnattingius S. Cigarette smoking as a risk factor for sudden infant death syndrome: a population-based study. Am. J. Public Health. 80:1990;29-32.
24. 3H]cytisine binding to human brain membrane preparations Brain Res. 600:1993;127-133.
25. Hellström-Lindahl E., Zhang X., Nordberg A. Expression of nicotinic receptor subunit mRNAs in lymphocytes from normal and patients with Alzheimer's disease. Alzheimer's Res. 3:1997;29-36.
26. 3H]epibatidine binding to nicotinic cholinergic receptors in brain Med. Chem. Res. 4:1994;538-546.
27. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain Mol. Pharmacol. 48:1995;280-287.
28. Ivanshina A.Z. Development of synaptic contacts in the human brain at early stages in embryogenesis. Zh. Neuropat. Psikhiat. 76:1976;983-989.
29. Kellar K.J. Epibatidine: its pharmacological actions and utility for studying neuronal nicotinic receptors. Neurotransmissions. 11:1995;1-5.
30. 3H] nicotine binding in the human brainstem Neuroscience. 55:1993;1127-1138.
31. Levin E.D., Wilkerson A., Jones J.P., Christopher N.C., Briggs S.J. Prenatal nicotine effects on memory in rats: pharmacological and behavioural challenges. Dev. Brain Res. 97:1996;207-215.
32. Lipton S.A., Frosch M.P., Phillips M.D., Tauck D.L., Aizenman E. Nicotinic antagonists enhance process outgrowth by rat retinal ganglion cells in culture. Science. 239:1988;1293-1296.
33. Lipton S.A., Kater S.B. Neurotransmittor regulation of neuronal outgrowth, plasticity and survival. Trend. Neurol. Sci. 12:1989;265-270.
34. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
35. Luck W., Nau H., Hansen R., Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev. Pharmacol. Ther. 8:1985;384-395.
36. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
37. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., Slotkin T.A. Effects of prenatal nicotine exposure on the development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251:1989;894-900.
38. Nordberg A., Zhang X., Fredriksson A., Eriksson P. Neonatal nicotine exposure induces permanent changes in the brain nicotine receptors and behaviour of adult mice. Dev. Brain Res. 63:1991;201-207.
39. Nordberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31:1992;103-111.
40. Olson L., Strömberg L., Bygdeman M., Granholm A.C., Hoffer B., Freedman R., Seiger Å. Human fetal tissues grafted to rodent hosts: structural and functional observations of brain, adrenal, and heart tissues in oculo. Exp. Brain Res. 67:1987;163-178.
41. Pauly J., Marks M., Gross S., Collins A. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J. Pharmacol. Exp. Ther. 258:1991;1127-1136.
42. Perry E.K., Smith C.J., Atack J.R., Candy J.M., Johnson M., Perry R.H. Neocortical cholinergic enzyme and receptor activities in the human fetal brain. J. Neurochem. 47:1986;1262-1269.
43. 3H] epibatidine labels nicotinic receptors in rat brain: an autoradiographic study J. Pharmacol. Exp. Ther. 275:1995;1030-1034.
44. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
45. Rubboli F., Court J.A., Sala C., Morris C., Chini B., Perry E., Clementi F. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6:1994;1596-1604.
46. Sanderson E.M., Drasdo A.L., McCrea K., Wonnacott S. Upregulation of nicotinic receptors following continues infusion of nicotine is brain region specific. Brain Res. 617:1993;349-352.
47. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
48. Seiger Å. Collection and use of fetal central nervous system tissue. Fetal Ther. 4:1989;104-107.
49. 3H] nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions J. Pharmacol. Exp. Ther. 242:1987;232-237.
50. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2, and β4 subunits. J. Biol. Chem. 272:1996;17656-17665.
51. Weitzman M., Gortmaker S., Sobol A. Maternal smoking and behaviour problems in children. Pediatrics. 90:1992;342-349.
52. Wevers A., Jeske A., Lobron Ch., Birtsch Ch., Heinemann S., Maelicke A., Schröder R., Schröder H. Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization. Mol. Brain Res. 25:1994;122-128.
53. Wevers A., Sullivan J.P., Giordano T., Birtsch Ch., Monteggia L.M., Nowacki S., Arneric S., Schröder H. Cellular distribution of the mRNA for the α7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex. Drug Dev. Res. 36:1995;103-110.
54. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
55. Whyte J., Harrison R., Lunt G.G., Wonnacott S. Properties of α-bungarotoxin binding sites in foetal human brain. Neurochem. Int. 7:1985;515-523.
56. Yamada S., Yoshiyuka K., Mitsutaka I., Takayanagi N., Hayashi E. Ontogenesis of nicotinic acetylcholine receptors and presynaptic cholinergic neurons in mammalian brain. Life Sci. 38:1986;637-644.
57. Zhang X., Wahlström G., Nordberg A. Influence of development and aging in nicotinic receptor subtypes in rodent brain. Int. J. Dev. Neurosci. 8:1990;715-721.
58. Zhang X., Gong Z.-H., Nordberg A. Effects of chronic treatment with (+)-and (-)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain. Brain Res. 644:1994;32-39.
59. Zoli M., Le Novere N., Hill J.A., Changeux J.P. Developmental regulation of nicotinic receptor subunit mRNAs in the rat central and peripheral nervous system. J. Neurosci. 15:1995;1912-1939.